Marizyme is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.
Company profile
Ticker
MRZM
Exchange
Website
CEO
Ralph Makar
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GBS Enterprises Inc, MARIZYME INC, Swav Enterprises Ltd.
SEC CIK
Corporate docs
Subsidiaries
Marizyme Sciences, Inc. • Somaceutica, Inc. • Somahlution, Inc. • My Health Logic Inc., a corporation incorporated ...
MRZM stock data
Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
1 Apr 24
424B3
Prospectus supplement
6 Feb 24
8-K
Departure of Directors or Certain Officers
6 Feb 24
424B3
Prospectus supplement
29 Dec 23
8-K
Entry into a Material Definitive Agreement
28 Dec 23
424B3
Prospectus supplement
22 Nov 23
8-K
Entry into a Material Definitive Agreement
21 Nov 23
424B3
Prospectus supplement
16 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
424B3
Prospectus supplement
24 Oct 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2022
3.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 4.86 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ESC | 2.56 mm | $0.00 |
Marine Bio SPA | 2.31 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Dec 23 | Lichti Braeden | Common stock | Conversion | Dispose C | Yes | No | 0.1 | 3,815,294 | 381.53 k | 13,293,841 |
21 Dec 23 | Lichti Braeden | 10% Secured Convertible Promissory Note Common Stock | Conversion | Dispose C | Yes | No | 0.1 | 2 | 0.20 | - |
29 Aug 23 | Lichti Braeden | Common shares | Sell | Dispose S | Yes | No | 0.165 | 105,000 | 17.33 k | 9,478,547 |
7 Jul 23 | Lichti Braeden | Common shares | Sell | Dispose S | Yes | No | 0.1 | 97,000 | 9.70 k | 9,583,547 |
29 Jun 23 | Lichti Braeden | Common shares | Sell | Dispose S | Yes | No | 0.09 | 106,327 | 9.57 k | 9,680,547 |
14 Apr 23 | Dhaduk Vithalbhai D | Common Stock | Grant | Acquire A | Yes | No | 0.1 | 1,063,938 | 106.39 k | 4,610,548 |
14 Apr 23 | Dhaduk Vithalbhai D | Warrant Common Stock | Sale back to company | Dispose D | Yes | No | 0.1 | 1,063,938 | 106.39 k | 0 |
14 Apr 23 | Dhaduk Vithalbhai D | Warrant Common Stock | Grant | Acquire A | Yes | No | 0.1 | 1,063,938 | 106.39 k | 1,063,938 |
14 Apr 23 | Dhaduk Vithalbhai D | Warrant Common Stock | Sale back to company | Dispose D | Yes | No | 5 | 1,063,938 | 5.32 mm | 0 |